Brennan Kevin M.
- SEC CIK
- 0001971303
In the past year, 1 open-market sale filing worth $1.17K and no purchases.
Current role at each company
- XLO Xilio Therapeutics, Inc.SVP, FINANCE AND ACCOUNTINGas of Jan 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.17K
- 1 filing
- Net
- −$1.17K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brennan Kevin M. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | SSale | −1.83K | $0.64 | −$1.17K | −22.3%6.37K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Jan 2 | 1 day | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | SSale | −1.80K | $0.98 | −$1.77K | −36.1%3.20K after | 10b5-1 |